[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 75)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.8,"TPM_sd":12.58,"TPM_min":0.04,"TPM_25th_percentile":0.99,"TPM_median":2.27,"TPM_75th_percentile":5.9,"TPM_max":99.31},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.47,"TPM_sd":0.38,"TPM_min":0,"TPM_25th_percentile":0.2,"TPM_median":0.38,"TPM_75th_percentile":0.55,"TPM_max":1.62},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.37,"TPM_sd":1.02,"TPM_min":0.13,"TPM_25th_percentile":0.61,"TPM_median":1.34,"TPM_75th_percentile":1.73,"TPM_max":4.1},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.13,"TPM_sd":3.88,"TPM_min":0.74,"TPM_25th_percentile":1.47,"TPM_median":2.72,"TPM_75th_percentile":6.16,"TPM_max":15.03},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.86,"TPM_sd":8.17,"TPM_min":0,"TPM_25th_percentile":0.15,"TPM_median":0.3,"TPM_75th_percentile":7.3,"TPM_max":14.29},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.35,"TPM_sd":16.29,"TPM_min":0.59,"TPM_25th_percentile":1.06,"TPM_median":2.68,"TPM_75th_percentile":4.02,"TPM_max":38.38},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.81,"TPM_sd":4.19,"TPM_min":0.35,"TPM_25th_percentile":2.09,"TPM_median":4,"TPM_75th_percentile":5.8,"TPM_max":13.48},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.33,"TPM_sd":7.05,"TPM_min":0.19,"TPM_25th_percentile":0.26,"TPM_median":0.34,"TPM_75th_percentile":6.4,"TPM_max":12.47},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.04,"TPM_sd":11.48,"TPM_min":1.22,"TPM_25th_percentile":2.65,"TPM_median":7.03,"TPM_75th_percentile":10.5,"TPM_max":32.11},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.44,"TPM_sd":6.87,"TPM_min":1.8,"TPM_25th_percentile":4.16,"TPM_median":8.19,"TPM_75th_percentile":15.42,"TPM_max":17.81},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 48)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":48,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.85,"TPM_sd":3.83,"TPM_min":0.17,"TPM_25th_percentile":1.85,"TPM_median":4.02,"TPM_75th_percentile":6.87,"TPM_max":16.79},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.45,"TPM_sd":4.7,"TPM_min":4.91,"TPM_25th_percentile":6.26,"TPM_median":7.26,"TPM_75th_percentile":12.81,"TPM_max":17.78},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 47)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.96,"TPM_sd":2.82,"TPM_min":0.07,"TPM_25th_percentile":0.7,"TPM_median":1.91,"TPM_75th_percentile":4.84,"TPM_max":12.31},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.83,"TPM_sd":4.21,"TPM_min":0,"TPM_25th_percentile":3.38,"TPM_median":6.77,"TPM_75th_percentile":7.24,"TPM_max":7.72},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.33,"TPM_sd":2.55,"TPM_min":0.3,"TPM_25th_percentile":0.86,"TPM_median":1.25,"TPM_75th_percentile":2.55,"TPM_max":8.99},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.12,"TPM_sd":9.13,"TPM_min":0.53,"TPM_25th_percentile":1.15,"TPM_median":5.93,"TPM_75th_percentile":12.82,"TPM_max":22.46},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 50)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":50,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.15,"TPM_sd":21.94,"TPM_min":0.34,"TPM_25th_percentile":0.95,"TPM_median":3.63,"TPM_75th_percentile":7.27,"TPM_max":133.7},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.62,"TPM_sd":10,"TPM_min":0.66,"TPM_25th_percentile":3.42,"TPM_median":9.62,"TPM_75th_percentile":16.83,"TPM_max":22.57},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 78)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":78,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.95,"TPM_sd":4.31,"TPM_min":0.05,"TPM_25th_percentile":1.64,"TPM_median":2.8,"TPM_75th_percentile":5.06,"TPM_max":34.48},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.81,"TPM_sd":1.26,"TPM_min":0.45,"TPM_25th_percentile":1.28,"TPM_median":1.66,"TPM_75th_percentile":2.19,"TPM_max":3.49},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":32.39,"TPM_sd":28.81,"TPM_min":1.35,"TPM_25th_percentile":13.58,"TPM_median":23.41,"TPM_75th_percentile":43.94,"TPM_max":128.46},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 11)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":11,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.76,"TPM_sd":0.68,"TPM_min":0.04,"TPM_25th_percentile":0.3,"TPM_median":0.42,"TPM_75th_percentile":1.12,"TPM_max":2.05},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":44.12,"TPM_sd":43.03,"TPM_min":0.3,"TPM_25th_percentile":14.66,"TPM_median":35.8,"TPM_75th_percentile":51.05,"TPM_max":141.13},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.17,"TPM_sd":15.04,"TPM_min":0.3,"TPM_25th_percentile":2.4,"TPM_median":12.84,"TPM_75th_percentile":24.85,"TPM_max":37.25},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":65.84,"TPM_sd":44.94,"TPM_min":13.26,"TPM_25th_percentile":38.32,"TPM_median":48.88,"TPM_75th_percentile":88.86,"TPM_max":141.13},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.5,"TPM_sd":0.26,"TPM_min":0.1,"TPM_25th_percentile":0.36,"TPM_median":0.56,"TPM_75th_percentile":0.63,"TPM_max":0.83},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 26)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.24,"TPM_sd":2,"TPM_min":0.06,"TPM_25th_percentile":0.74,"TPM_median":1.71,"TPM_75th_percentile":3.47,"TPM_max":8.05},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.43,"TPM_sd":6.19,"TPM_min":1.52,"TPM_25th_percentile":2.96,"TPM_median":4.39,"TPM_75th_percentile":8.88,"TPM_max":13.38},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":23.72,"TPM_sd":37.1,"TPM_min":1.76,"TPM_25th_percentile":1.79,"TPM_median":7.14,"TPM_75th_percentile":29.07,"TPM_max":78.85},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.53,"TPM_sd":3.91,"TPM_min":0.09,"TPM_25th_percentile":0.48,"TPM_median":0.72,"TPM_75th_percentile":1.27,"TPM_max":10.72},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.01,"TPM_sd":0.77,"TPM_min":0.33,"TPM_25th_percentile":0.54,"TPM_median":0.8,"TPM_75th_percentile":1.27,"TPM_max":2.08},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.23,"TPM_sd":0.14,"TPM_min":0.07,"TPM_25th_percentile":0.17,"TPM_median":0.27,"TPM_75th_percentile":0.31,"TPM_max":0.35},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.42,"TPM_sd":3.03,"TPM_min":2.15,"TPM_25th_percentile":5.35,"TPM_median":5.95,"TPM_75th_percentile":8.88,"TPM_max":9.75},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 13)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.75,"TPM_sd":19.3,"TPM_min":1.2,"TPM_25th_percentile":2.4,"TPM_median":4.01,"TPM_75th_percentile":17.67,"TPM_max":69.9},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 14)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":26.63,"TPM_sd":16.71,"TPM_min":4.4,"TPM_25th_percentile":13.83,"TPM_median":27.83,"TPM_75th_percentile":33.23,"TPM_max":58.78},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 5)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.07,"TPM_sd":2.47,"TPM_min":0.08,"TPM_25th_percentile":0.37,"TPM_median":1.25,"TPM_75th_percentile":2.47,"TPM_max":6.16},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 3)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.74,"TPM_sd":1.13,"TPM_min":1.02,"TPM_25th_percentile":1.08,"TPM_median":1.15,"TPM_75th_percentile":2.09,"TPM_max":3.04}]